Total Funding
57
61
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
113967
Cognos Therapeutics is a developer of diagnostic and drug delivery devices to detect diseases and deliver drugs.
Roger Kornberg: Co-Founder- Frank Adell: Co-Founder and CEO
About the Company
Cognos Therapeutics is a medical device company that develops diagnostic and drug delivery devices designed to detect diseases and deliver drugs. The company's devices radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma
occurrences, and other Central Nervous System afflictions that enable doctors to detect diseases, monitor their patients, and deliver medicines as per requirements.
Cognos Therapeutics was established in 2003 and is headquartered in Inglewood, California.
